SemBioSys reacquires rights to DermaSphere(R) Oleosome Technology - Drug Newswire (press release)
SemBioSys reacquires rights to DermaSphere(R) Oleosome Technology - Drug Newswire (press release)
SemBioSys reacquires rights to DermaSphere(R) Oleosome TechnologyDrug Newswire (press release), CT - 29 minutes agoSemBioSys will continue to manufacture and supply DermaSphere(R) to the personal care market to address the burgeoning demand for the technology and the …